Az oldal megfelelő megjelenítéséhez engedélyezze böngészőjében a JavaScript használatát!

You are here

Botó Pál

Botó Pál

Department of Biochemistry and Molecular Biology

Name: Botó Pál

Other profiles: LinkedIn, ResearchGate

Profession: Stem cell research

Publication list

printer-friendly version

Export to MTMT compatible RIS file
Upload publications
Request certified publication list

Uploaded publications:

11

Publications in DEA:

11

OA:

9

Date range:

2016-2024

2024

Kolostyák, Z., Bojcsuk, D., Baksa, V., Máthéné Szigeti, Z., Bene, K., Czimmerer, Z., Botó, P., Fadel, L., Póliska, S., Halász, L., Tzerpos, P., Berger, W., Villabona-Rueda, A., Varga, Z., Kovács, T., Patsalos, A., Pap, A., Vámosi, G., Bai, P., Dezső, B., Spite, M., D'Alessio,, F., Szatmári, I., Nagy, L.: EGR2 is an epigenomic regulator of phagocytosis and antifungal immunity in alveolar macrophages.
JCI Insight. 9 (17), 1-21, 2024.

Journal metrics:

D1 Medicine (miscellaneous) (2023)

2023

Jambrovics, K., Botó, P., Pap, A., Sarang, Z., Kolostyák, Z., Czimmerer, Z., Szatmári, I., Fésüs, L., Uray, I., Balajthy, Z.: Transglutaminase 2 associated with PI3K and PTEN in a membrane-bound signalosome platform blunts cell death.
Cell Death Dis. 14 (3), 1-10, 2023.

Journal metrics:

Q1 Cancer Research
Q1 Cell Biology
Q1 Cellular and Molecular Neuroscience
Q1 Immunology
D1 Medicine (miscellaneous)

2021

Douida, A., Batista, F., Botó, P., Regdon, Z., Robaszkiewicz, A., Tar, K.: Cells Lacking PA200 Adapt to Mitochondrial Dysfunction by Enhancing Glycolysis via Distinct Opa1 Processing.
Int. J. Mol. Sci. 22 (4), 1-22, 2021.

Journal metrics:

Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
Botó, P., Gerzsenyi, T., Lengyel, A., Szúnyog, B., Szatmári, I.: Zbtb46-dependent altered developmental program in embryonic stem cell-derived blood cell progenitors.
Stem Cells. 39 (10), 1322-1334, 2021.

Journal metrics:

Q2 Cell Biology
Q1 Developmental Biology
Q1 Medicine (miscellaneous)
Q1 Molecular Medicine

2020

Douida, A., Batista, F., Robaszkiewicz, A., Botó, P., Aladdin, A., Szenykiv, M., Czinege, R., Virág, L., Tar, K.: The proteasome activator PA200 regulates expression of genes involved in cell survival upon selective mitochondrial inhibition in neuroblastoma cells.
J. Cell. Mol. Med. 24 (12), 6716-6730, 2020.

Journal metrics:

Q2 Cell Biology
Q1 Molecular Medicine
Dániel, B., Czimmerer, Z., Halász, L., Botó, P., Kolostyák, Z., Póliska, S., Berger, W., Tzerpos, P., Nagy, G., Horváth, A., Hajas, G., Silye-Cseh, T., Nagy, A., Sauer, S., Francois-Deleuze, J., Szatmári, I., Bácsi, A., Nagy, L.: The transcription factor EGR2 is the molecular linchpin connecting STAT6 activation to the late, stable epigenomic program of alternative macrophage polarization.
Genes Dev. 34 (21-22), 1474-1492, 2020.

Journal metrics:

D1 Developmental Biology
D1 Genetics

2019

Aladdin, A., Király, R., Botó, P., Regdon, Z., Tar, K.: Juvenile Huntington's disease skin fibroblasts respond with elevated parkin level and increased proteasome activity as a potential mechanism to counterbalance the pathological consequences of mutant huntingtin protein.
Int. J. Mol. Sci. 20 (21), 1-39, 2019.

Journal metrics:

Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
Q1 Spectroscopy

2018

Botó, P., Csuth, T., Szatmári, I.: RUNX3-Mediated Immune Cell Development and Maturation.
Crit. Rev. Immunol. 38 (1), 63-78, 2018.

Journal metrics:

Q3 Immunology
Q3 Immunology and Allergy

2017

Takács, E., Botó, P., Simó, E., Csuth, T., Tóth, B., Raveh-Amit, H., Pap, A., Kovács, E., Kobolák, J., Benkő, S., Dinnyés, A., Szatmári, I.: Immunogenic Dendritic Cell Generation from Pluripotent Stem Cells by Ectopic Expression of Runx3.
J. Immunol. 198 (1), 239-248, 2017.

Journal metrics:

Q1 Immunology
Kiss, M., Czimmerer, Z., Nagy, G., Bieniasz-Krzywiec, P., Ehling, M., Pap, A., Póliska, S., Botó, P., Tzerpos, P., Horváth, A., Kolostyák, Z., Dániel, B., Szatmári, I., Mazzone, M., Nagy, L.: Retinoid X receptor suppresses a metastasis-promoting transcriptional program in myeloid cells via a ligand-insensitive mechanism.
Proc. Natl. Acad. Sci. U. S. A. 114 (40), 10725-10730, 2017.

Journal metrics:

D1 Multidisciplinary

2016

Bencsik, R., Botó, P., Szabó, R., Tóth, B., Simó, E., Bálint, B., Szatmári, I.: Improved transgene expression in doxycycline-inducible embryonic stem cells by repeated chemical selection or cell sorting.
Stem Cell Res. 17 (2), 228-234, 2016.

Journal metrics:

Q2 Cell Biology
Q1 Developmental Biology
D1 Medicine (miscellaneous)

updated: 2024-11-10, 02:10